Hansoh Pharmaceutical Group Co (HKSE:03692) Accounts Payable : HK$179 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Hansoh Pharmaceutical Group Co Accounts Payable?

Hansoh Pharmaceutical Group Co's Accounts Payable for the quarter that ended in Dec. 2023 was HK$179 Mil.

Hansoh Pharmaceutical Group Co's quarterly Accounts Payable increased from Dec. 2022 (HK$248 Mil) to Jun. 2023 (HK$326 Mil) but then declined from Jun. 2023 (HK$326 Mil) to Dec. 2023 (HK$179 Mil).

Hansoh Pharmaceutical Group Co's annual Accounts Payable declined from Dec. 2021 (HK$304 Mil) to Dec. 2022 (HK$248 Mil) and declined from Dec. 2022 (HK$248 Mil) to Dec. 2023 (HK$179 Mil).

Hansoh Pharmaceutical Group Co Accounts Payable Historical Data

The historical data trend for Hansoh Pharmaceutical Group Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansoh Pharmaceutical Group Co Accounts Payable Chart

Hansoh Pharmaceutical Group Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

214.59

147.45

304.07

248.24

179.12

Hansoh Pharmaceutical Group Co Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable	Get a 7-Day Free Trial									304.07	280.87	248.24	326.41	179.12

Hansoh Pharmaceutical Group Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Hansoh Pharmaceutical Group Co Accounts Payable Related Terms

Thank you for viewing the detailed overview of Hansoh Pharmaceutical Group Co's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Hansoh Pharmaceutical Group Co (HKSE:03692) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) » Definitions » Accounts Payable

Traded in Other Exchanges

3KY:Germany

Address

287 Xiangke Road, Pudong New District, Shanghai, CHN, 201210

Website

https://www.hspharm.com

Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.

Executives

Cen Junda	2307 Founder of a discretionary trust who can infl
Cantrust (far East) Limited	2301 Trustee
Jqc Holding Limited	2201 Interest of corporation controlled by you
Jqc International Limited	2201 Interest of corporation controlled by you
Sun Yuan	2101 Beneficial owner
Harmonia Holding Investing (ptc) Limited	2201 Interest of corporation controlled by you
Stellar Infinity Company Ltd.	2101 Beneficial owner
Sunrise Investment Advisors Limited	2201 Interest of corporation controlled by you
Zhong Huijuan	2307 Founder of a discretionary trust who can infl
Apex Medical Company Ltd.	2101 Beneficial owner

Hansoh Pharmaceutical Group Co (HKSE:03692) Headlines

No Headlines